Ozempic
Semaglutide
Ozempic (semaglutide) is a once-weekly injectable medication from Novo Nordisk, FDA-approved for type 2 diabetes management. By mimicking the GLP-1 hormone, Ozempic helps regulate blood sugar, lower A1C levels, and reduce the risk of major cardiovascular events in adults with diabetes. Beyond diabetes, Ozempic has gained attention for its off-label use in weight loss, as it curbs appetite and promotes sustained weight reduction. Its convenient once-weekly dosing and proven effectiveness make it a leading GLP-1 therapy. Patients often consider Ozempic as a trusted solution for managing both blood sugar and weight under medical supervision.
- Manufacturer: Novo Nordisk
- Primary Use: Type 2 diabetes management (with off-label weight loss benefits)
- Form: Injectable
Common Side Effects
The most common side effects of Ozempic may include:
- Nausea
- Vomiting
- Constipation
- Abdominal Pain
- Diarrhea
This is not a complete list. Always consult with your healthcare provider about potential side effects.
Medical Disclaimer
The information provided for Ozempic is for informational purposes only and is not a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or treatment. Read our full disclaimer.